iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Clarity Wealth Advisors LLC

Clarity Wealth Advisors LLC lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 16.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,829 shares of the financial services provider’s stock after selling 2,771 shares during the quarter. Clarity Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $2,014,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Future Financial Wealth Managment LLC bought a new stake in iShares Biotechnology ETF in the first quarter valued at about $27,000. Bbjs Financial Advisors LLC bought a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at approximately $31,000. Pacifica Partners Inc. raised its position in shares of iShares Biotechnology ETF by 118.2% during the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after acquiring an additional 130 shares in the last quarter. Mather Group LLC. acquired a new position in iShares Biotechnology ETF in the first quarter worth $57,000. Finally, Chris Bulman Inc bought a new stake in iShares Biotechnology ETF during the second quarter valued at $64,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.2 %

Shares of iShares Biotechnology ETF stock traded up $0.22 during trading hours on Friday, reaching $145.91. The company’s stock had a trading volume of 815,270 shares, compared to its average volume of 1,466,877. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $150.57. The company’s 50 day simple moving average is $145.65 and its 200 day simple moving average is $139.65.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.